
However, the clinical laboratory services market may face challenges due to stringent regulatory issues in various countries and a lack of skilled laborers. The increasing awareness about early disease diagnosis and the launch of technologically advanced products are also contributing to the market's growth. The demand for clinical diagnostic tests is increasing due to the rising burden of diseases like cancer and tuberculosis. The market is driven by the rising incidence of chronic and infectious diseases, increasing demand for accurate and early disease diagnosis techniques, and the growing burden of cancer. Many companies, such as Thermo Fisher Scientific, launched new products to enhance COVID-19 testing capacity. During the pandemic, there was an increase in demand for clinical diagnostics and testing technology, including molecular and serological testing for severe COVID-19 infections, leading to an overall increase in demand for clinical laboratory services. The COVID-19 pandemic has had a positive impact on the clinical laboratory services market. COVID-19 Impact on the Clinical Laboratory Services Market The clinical laboratory services market is projected to grow from USD 261.01 billion in 2023 to USD 357.44 billion by 2028, at a CAGR of 6.49% during the forecast period (2023-2028).



Global Clinical Laboratory Services Market 2023-2028: Featuring Key Players Fresenius Medical Care, Genova Diagnostics, Sonic Healthcare & More
